Table 2.
Schedule of study activities and follow-up
| Enrolment | Month 1 | Month 2 | Month 3 | Month 4 | Month 5 | Month 6 | Month 7 | |
| POC arm | ||||||||
| Consent/randomisation | X | |||||||
| Baseline questionnaire | X | |||||||
| Adherence assessment | X | X | X | |||||
| VL knowledge questionnaire | X | X | ||||||
| Acceptability questionnaire | X | |||||||
| VL test (Xpert) | X | X* | X | |||||
| VL test (Abbott) | X | |||||||
| Dried blood spot (DBS) collection | X | X | X | |||||
| Adherence counselling informed by VL result | X | X* | X | |||||
| SOC arm | ||||||||
| Consent/randomisation | X | |||||||
| Baseline questionnaire | X | |||||||
| Adherence assessment | X | X | X | |||||
| VL knowledge questionnaire | X | X | ||||||
| VL test (Abbott) | X | X* | X | |||||
| DBS collection | X | X | X | |||||
| Adherence counselling informed by VL result | X | X* | X | |||||
*Only if participant has VL >1000 copies/µL at month 1.
POC, point-of-care; SOC, standard of care; VL, viral load.